Dr. Alejandro Llanos was an invited lecturer in “The Malaria Endgame Meeting: Innovation in therapeutic tools, vector control and public health”


From October 30th to November 2nd “The Malaria Endgame Meeting: Innovation in Therapeutics, Vector Control and Public Health Tools” was held in Addis Ababa, Ethiopia. The conference is organized around three themes: defeating resistance (both to drugs and to insecticides), leveraging data science to better understand disease transmission and innovation in vector control strategies. This event is attended by leaders from prestigious institutions in relation to the aforementioned issues.

In this opportunity Dr. Alejandro Llanos, head of the Research Unit in Malaria and Leishmania and past Director of the Instituto de Medicina Tropical “Alexander von Humboldt” (IMT AvH), was invited as a lecturer at the “Innovation to enable Malaria Elimination” session. He presented about the clinical development and implementation of tafenoquine for P. vivax malaria, which is widespread in the Americas, the Horn of Africa and Asia.

Malaria is an important public health problem for Peru and worldwide. According to the latest WHO report, malaria cases were 219 million worldwide and there were an estimated 435000 deaths. In Peru, in 2018, 42 644 cases of malaria were reported, being Loreto the department with the highest number of cases (96%).

For more information visit:


Review meeting highlights: https://tks.keystonesymposia.org/index.cfm?e=Web.Meeting.Program&MeetingID=1704